Vorinostat Withdrawn Phase N/A Trials for Stage II Breast Cancer / Stage IIIA Breast Cancer / Triple-Negative Breast Cancer (TNBC) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01695057Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer